drug · small molecule
patient view →DIFLUPREDNATE
Marketedupdated 2mo agoby Ocuvex Therapeutics Inc🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 5 investigational indications.
targets
Glucocorticoid receptor
all catalysts(11)
approval · 11
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that